publication venue for
- The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors. 60:921-930. 2021
- Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach. 59:605-616. 2020
- Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup. 59:245-256. 2020
- Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent–Metabolite Population Pharmacokinetic Model. 55:1395-1411. 2016
- Population Pharmacokinetics of Intravenous Paracetamol (Acetaminophen) in Preterm and Term Neonates: Model Development and External Evaluation. 55:107-119. 2016
- Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development. 48:1-22. 2009
- Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery. 47:203-216. 2008
- Pharmacokinetic Optimisation of the Treatment of Deep Vein Thrombosis. 32:145-172. 1997
- Anti-Allergy and Anti-Asthma Drugs. 17:156-168. 1989
- DRUG DISPOSITION IN INFANCY AND CHILDHOOD SEMINAR-IN-PRINT - ROUND-TABLE DISCUSSION. 17:169-176. 1989